Nature, Published online: 11 March 2026; doi:10.1038/s41586-026-10244-w

A clinical trial testing whether monitoring ctDNA clearance during treatment for nasopharyngeal cancer could be used to inform decisions about an individual’s subsequent therapeutic programme shows promising results.

Nature Cancer, Published online: 05 March 2026; doi:10.1038/s43018-026-01135-0

Dong and colleagues report that blockade of T cell-expressed cytotoxic and regulatory T cell molecule results in selective mitigation of immune-related toxicities without affecting antitumor efficacy of immune checkpoint inhibitors.

arXiv:2507.01335v3 Announce Type: replace-cross Abstract: Autoregressive language models are trained exclusively left-to-right. We explore the complementary factorization, training right-to-left at scale, and ask what reasoning patterns emerge when a model conditions on future context to predict the past. We train LEDOM, an open-source purely reverse autoregressive language model (2B/7B parameters, 435B tokens), and find it develops capabilities distinct from forward models, including abductive inference, question synthesis, and natural resolution of the reversal curse. We then explore one application of the reverse model: combining forward likelihood $P(y \mid x)$ with reverse posterior $P(x \mid y)$ through noisy channel duality. We propose Reverse Reward, which reranks forward outputs using reverse posterior estimates, and prove that bidirectional scoring penalizes hallucinated reasoning chains whose backward reconstruction degrades. Reverse Reward yields gains of up to 6.6\% on AIME 2024 and 15\% on AMC 2023 across multiple strong baselines. We release all models, code, and data here.

arXiv:2602.14010v1 Announce Type: cross Abstract: Pathology foundation models (PFMs) have enabled robust generalization in computational pathology through large-scale datasets and expansive architectures, but their substantial computational cost, particularly for gigapixel whole slide images, limits clinical accessibility and scalability. Here, we present LitePath, a deployment-friendly foundational framework designed to mitigate model over-parameterization and patch level redundancy. LitePath integrates LiteFM, a compact model distilled from three large PFMs (Virchow2, H-Optimus-1 and UNI2) using 190 million patches, and the Adaptive Patch Selector (APS), a lightweight component for task-specific patch selection. The framework reduces model parameters by 28x and lowers FLOPs by 403.5x relative to Virchow2, enabling deployment on low-power edge hardware such as the NVIDIA Jetson Orin Nano Super. On this device, LitePath processes 208 slides per hour, 104.5x faster than Virchow2, and consumes 0.36 kWh per 3,000 slides, 171x lower than Virchow2 on an RTX3090 GPU. We validated accuracy using 37 cohorts across four organs and 26 tasks (26 internal, 9 external, and 2 prospective), comprising 15,672 slides from 9,808 patients disjoint from the pretraining data. LitePath ranks second among 19 evaluated models and outperforms larger models including H-Optimus-1, mSTAR, UNI2 and GPFM, while retaining 99.71% of the AUC of Virchow2 on average. To quantify the balance between accuracy and efficiency, we propose the Deployability Score (D-Score), defined as the weighted geometric mean of normalized AUC and normalized FLOP, where LitePath achieves the highest value, surpassing Virchow2 by 10.64%. These results demonstrate that LitePath enables rapid, cost-effective and energy-efficient pathology image analysis on accessible hardware while maintaining accuracy comparable to state-of-the-art PFMs and reducing the carbon footprint of AI deployment.

arXiv:2512.15829v2 Announce Type: replace-cross Abstract: Working memory enables the brain to integrate transient information for rapid decision-making. Artificial networks typically replicate this via recurrent or parallel architectures, yet incur high energy costs and noise sensitivity. Here we report IPNet, a hardware-software co-designed neuromorphic architecture realizing human-like working memory via neuronal intrinsic plasticity. Exploiting Joule-heating dynamics of Magnetic Tunnel Junctions (MTJs), IPNet physically emulates biological memory volatility. The memory behavior of the proposed architecture shows similar trends in n-back, free recall and memory interference tasks to that of reported human subjects. Implemented exclusively with MTJ neurons, the architecture with human-like working memory achieves 99.65% accuracy on 11-class DVS gesture datasets and maintains 99.48% on a novel 22-class time-reversed benchmark, outperforming RNN, LSTM, and 2+1D CNN baselines sharing identical backbones. For autonomous driving (DDD-20), IPNet reduces steering prediction error by 14.4% compared to ResNet-LSTM. Architecturally, we identify a 'Memory-at-the-Frontier' effect where performance is maximized at the sensing interface, validating a bio-plausible near-sensor processing paradigm. Crucially, all results rely on raw parameters from fabricated devices without optimization. Hardware-in-the-loop validation confirms the system's physical realizability. Separately, energy analysis reveals a reduction in memory power of 2,874x compared to LSTMs and 90,920x versus parallel 3D-CNNs. This capacitor-free design enables a compact ~1.5um2 footprint (28 nm CMOS): a >20-fold reduction over standard LIF neurons. Ultimately, we demonstrate that instantiating human-like working memory via intrinsic neuronal plasticity endows neural networks with the dual biological advantages of superior dynamic vision processing and minimal metabolic cost.